Picture of Tourmaline Bio logo

TRML — Tourmaline Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Novartis Completes Acquisition Of Tourmaline Bio

Oct 28 (Reuters) - Novartis AG NOVN.S:

NOVARTIS COMPLETES ACQUISITION OF TOURMALINE BIO

NOVARTIS AG - COMPLETES ACQUISITION OF TOURMALINE BIO

NOVARTIS AG - WITH COMPLETION OF ACQUISITION, SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE ( "SHARES") HAVE CEASED TRADING ON NASDAQ STOCK MARKET LLC

Source text: ID:nGNE1q3Pvk

Further company coverage: NOVN.S

 (Gdansk Newsroom)

 (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))

Recent news on Tourmaline Bio

See all news